Abstract | BACKGROUND: METHODS: From March 1991 to March 2006, 763 lung or heart-lung transplants were performed at our center. Fifty-eight patients (7.6%) required early (0 to 7 days after transplant) ECMO support for PGD. Venovenous or venoarterial ECMO was implemented (32 and 26 cases) depending on the patient's hemodynamic stability, surgeon's preference, and the era of transplantation. Mean duration of support was 5.5 days (range, 1 to 20). Mean follow-up was 4.5 years. RESULTS: Thirty-day and 1- and 5-year survivals were 56%, 40%, and 25%, respectively, for the entire group. Thirty-nine patients were weaned from ECMO, 21 venovenous and 18 venoarterial (53.8% and 46.2%), with 1- and 5-year survivals of 59% and 33%, inferior to recipients not requiring ECMO (p = 0.05). Survival at 30 days and at 1 and 5 years was similar for the patients supported with venoarterial or venovenous ECMO (58% versus 55%, p = 0.7; 42% versus 39%, p = 0.8; 29% versus 22%, p = 0.6). CONCLUSIONS:
|
Authors | Christian A Bermudez, Prasad S Adusumilli, Kenneth R McCurry, Diana Zaldonis, Maria M Crespo, Joseph M Pilewski, Yoshiya Toyoda |
Journal | The Annals of thoracic surgery
(Ann Thorac Surg)
Vol. 87
Issue 3
Pg. 854-60
(Mar 2009)
ISSN: 1552-6259 [Electronic] Netherlands |
PMID | 19231405
(Publication Type: Journal Article)
|
Topics |
- Adult
- Extracorporeal Membrane Oxygenation
- Female
- Humans
- Lung Transplantation
- Male
- Middle Aged
- Primary Graft Dysfunction
(mortality, therapy)
- Retrospective Studies
- Survival Rate
- Time Factors
|